Clinical trials
Terminated Phase 1 Graft vs Host Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Masonic Cancer Center, University of Minnesota | 2 |
| Massachusetts General Hospital | 2 |
| Alpine Immune Sciences, Inc. | 1 |
| Columbia University | 1 |
| Edwin Horwitz | 1 |
| Eisai Inc. | 1 |
| Gilead Sciences | 1 |
| IRCCS San Raffaele | 1 |
| Incyte Corporation | 1 |
| Karolinska Institutet | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Graft vs Host Disease | 18 |
| Leukemia | 5 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 |
| Lymphoma | 4 |
| Multiple Myeloma | 4 |
| Myelodysplastic Syndromes | 4 |
| Neoplasms, Plasma Cell | 4 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 |
| Lymphoma, Mantle-Cell | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.